Nyrada Inc - Chess Depository Int

NEW
ASX:NYR (Australia)   Chess Depository Interest
A$ 0.74 +0.015 (+2.07%) Sep 7
At Loss
P/B:
18.97
Market Cap:
A$ 183.22M ($ 132.27M)
Enterprise V:
A$ 174.83M ($ 126.21M)
Volume:
80.16K
Avg Vol (2M):
325.89K
Trade In:
Volume:
80.16K
At Loss
Avg Vol (2M):
325.89K

Business Description

Nyrada Inc
NAICS : 325412 SIC : 2834
ISIN : AU0000070195

Share Class Description:

ASX:NYR: Chess Depository Interest
Description
Nyrada Inc is a clinical-stage biotechnology company focused on the discovery and development of small-molecule therapies, specifically targeting Transient Receptor Potential Canonical (TRPC) ion channels. Its flagship candidate, Xolatryp, is being developed for applications in cardioprotection and neuroprotection. The company operates in one segment being research and development of drugs focusing on small molecules with potential therapeutic benefit in areas of medical need and it operates in one geographical area being Australasia.
Name Current Vs Industry Vs History
Cash-To-Debt
No Debt
Equity-to-Asset
0.92
Interest Coverage
No Debt
Piotroski F-Score
3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate
14.9
3-Year EPS without NRI Growth Rate
18.6
3-Year FCF Growth Rate
25.5
3-Year Book Growth Rate
13
Name Current Vs Industry Vs History
5-Day RSI
44.87
9-Day RSI
49.56
14-Day RSI
53.15
3-1 Month Momentum %
51.02
6-1 Month Momentum %
17
12-1 Month Momentum %
155.17

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
11.94
Quick Ratio
11.94
Cash Ratio
9.64

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio
-16.6
Shareholder Yield %
-5.57
Name Current Vs Industry Vs History
ROE %
-85.66
ROA %
-75.33
ROIC %
-495
3-Year ROIIC %
85.65
ROC (Joel Greenblatt) %
-616.92
ROCE %
-114.24

GF Value Rank

Name Current Vs Industry Vs History
PB Ratio
18.97
Price-to-Tangible-Book
18.5
EV-to-EBIT
-19.98
EV-to-EBITDA
-19.98
EV-to-FCF
-37.83
Price-to-Net-Current-Asset-Value 18.5
Price-to-Net-Cash 24.67
Earnings Yield (Greenblatt) %
-5
FCF Yield %
-2.47

Financials

ASX:NYR's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

Nyrada Inc Executives

Details

GF Valueâ„¢

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil A$)
EPS (TTM) (A$) -0.028
Beta -0.598
3-Year Sharpe Ratio 1.02
3-Year Sortino Ratio 5.35
Volatility % 185.05
14-Day RSI 53.15
14-Day ATR (A$) 0.054192
20-Day SMA (A$) 0.7525
12-1 Month Momentum % 155.17
52-Week Range (A$) 0.25 - 1.435
Shares Outstanding (Mil) 247.59

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Nyrada Inc Filings

Filing Date Document Date Form
No Filing Data

Nyrada Inc Stock Events

Financials Calendars
Event Date Price (A$)
No Event Data

Nyrada Inc Frequently Asked Questions

What is Nyrada Inc(ASX:NYR)'s stock price today?
The current price of ASX:NYR is A$0.74. The 52 week high of ASX:NYR is A$1.44 and 52 week low is A$0.25.
When is next earnings date of Nyrada Inc(ASX:NYR)?
The next earnings date of Nyrada Inc(ASX:NYR) is .
Does Nyrada Inc(ASX:NYR) pay dividends? If so, how much?
Nyrada Inc(ASX:NYR) does not pay dividend.

Press Release

Subject Date
No Press Release

Articles on Nyrada Inc

No articles.